Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Gastroenterologie Clinique Et Biologique|January 1, 1990
Helicobacter-like organisms in gastroduodenal diseasesV Andreica, D Dumitrascu, N Sască, et al.The European Respiratory Journal|September 4, 1998
Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern EuropeB Björkstén, D Dumitrascu, T Foucard, et al.Research in Social & Administrative Pharmacy : RSAP|July 26, 2023
Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adultsC Bucsa, M Onea, A Rusu, et al.Neurogastroenterology and Motility|March 31, 2015
A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndromeC D Gerson, M-J Gerson, L Chang, et al.BMJ (Clinical Research Ed.)|January 6, 2012
Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trialN Beckett, R Peters, J Tuomilehto, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 22, 2018
Diagnosis and Treatment of Colonic Diverticular Disease: Position Paper of the Romanian Society of Gastroenterology and HepatologyAnca Trifan, Cristian Gheorghe, Cristina Marica Sabo, et al.Neurogastroenterology and Motility|June 21, 2016
Phenotyping of subjects for large scale studies on patients with IBSG E Boeckxstaens, V Drug, D Dumitrascu, et al.Alimentary Pharmacology & Therapeutics|September 2, 2014
Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team reportA D Sperber, K A Gwee, A P Hungin, et al.ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health recordsL Mazzeo, F Corso, P Baili, et al.Pageof 2